FDA Vaccine and Biotech Chief Dr. Vinay Prasad LEAVES Agency for SECOND Time in Under a Year

Dr. Vinay Prasad (Source: FDA)

The Food and Drug Administration (FDA) has confirmed that Dr. Vinay Prasad is leaving the agency for the second time in less than a year.

Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), will depart at the end of April, with no successor named yet.

Prasad was appointed in 2025 to lead the FDA’s Center for Biologics Evaluation and Research (CBER), the division responsible for regulating vaccines, blood products, and gene therapies.